Related Experiment Videos
Congenital soft tissue dysplasia: a new malformation entity and concept
D Pellerin1, H Martelli, X Latouche
1Dept. of Paediatric Surgery, Hôpital des Enfants Malades, Paris, France.
Insights
Congenital soft-tissue dysplasia (CSTD) is proposed to unify various conditions like hamartoma and gigantism in children. This benign condition stems from developmental cell dysregulation, guiding unified investigation and functional treatment approaches.
Area of Science:
- Pediatric Medicine
- Developmental Biology
- Pathology
Background:
- Previously, conditions such as giant hamartoma, angiodysplasia, congenital hypertrophy, congenital trophoedema, and localized gigantism were described separately.
- These diverse clinical manifestations in children share underlying developmental origins.
Purpose of the Study:
- To propose a unifying concept for a group of congenital soft-tissue conditions.
- To establish a common diagnostic and therapeutic framework for these disorders.
Main Methods:
- Clinical case reporting of 185 children with relevant conditions.
- Integration of recent advances in embryology and cell biology to explain pathogenesis.
- Development of a unified clinical investigation protocol and therapeutic plan.
Main Results:
- A single entity, congenital soft-tissue dysplasia (CSTD), is proposed to encompass these conditions.
- CSTD is hypothesized to result from dysregulation in embryonal or fetal cell biosynthesis.
- The proposed concept emphasizes the benign and stable nature of CSTD.
Conclusions:
- Congenital soft-tissue dysplasia (CSTD) offers a unified perspective on diverse pediatric soft-tissue abnormalities.
- Understanding CSTD's developmental origins informs clinical management.
- Treatment should prioritize functional improvement over cosmetic correction for CSTD.
Abstract:
We report 185 children with clinical manifestations of various conditions classically described as giant hamartoma, angiodysplasia, congenital hypertrophy, congenital trophoedema, localised gigantism (e.g. macrodactyly), etc. It is proposed to group all these conditions into a single entity: congenital soft-tissue dysplasia (CSTD). According to recent advances in fundamental embryology and cell biology, CSTD appears to be a consequence of embryonal or fetal cell biosynthetic dysregulation. The concept of the CSTD entity leads to a common protocol for clinical investigation and a common therapeutic plan, with special reference to the stability and the benign nature of the condition. Treatment should be confined to improving function rather than attempting to correct cosmetic deficits.